Mathai Mammen - 14 Jun 2023 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Reporting relationship: Director
Issuer ticker: TXG
Reported as of: 14 Jun 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jun 2023, 17:40:00 UTC
Prior SEC filing: 15 May 2023
Next SEC filing: 13 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Eric S. Whitaker, as Attorney-in-Fact for Mathai Mammen

Key filing fact

Mathai Mammen filed Form 4 for 10x Genomics, Inc. (TXG) on 16 Jun 2023.

Key facts

This page summarizes Mathai Mammen's Form 4 filing for 10x Genomics, Inc. (TXG).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 16 Jun 2023, 17:40.

Change

Previous filing in this sequence was filed on 15 May 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TXG transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +1,865
Change %: +1.1%
Price: $0.000000
Shares after: 171,610
Date: 14 Jun 2023
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TXG transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +4,661
Change %
Price: $0.000000
Shares after: 4,661
Date: 14 Jun 2023
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 4,661
Exercise price: $57.62
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2023, subject to the Reporting Person continuing as a service provider through each such date.

Footnote F2

1/12th of the total number of shares subject to the option vest on each monthly anniversary measured from June 14, 2023, subject to the Reporting Person continuing as a service provider through each such date.